Aortic Valve (TAVR/TAVI)Friday, September 25, 2026
Edwards Lifesciences stock heads into the open after a weaker session - AD HOC NEWS
1 min read·By E. Nolan Beckett, MD·Source: AD HOC NEWS
From The Valve Wire
The single-center two-era analysis published in Medical Sciences is the day's most instructive TAVR data — and its most misread.
Comparing 100 consecutive isolated TAVRs from 2012 with 100 from 2024, the 30-day composite of death or stroke fell from 10% to 1%, PVL ≥mild dropped from 27% to 3%, and hospital stay collapsed from 6 to 1 day (unadjusted, single-center, N=100 per era).
Editor’s take pending for this article; this is the section commentary excerpt.
Source Abstract
Edwards Lifesciences stock heads into the open after a weaker session AD HOC NEWS
Read the Original
Full article at AD HOC NEWS
Open at AD HOC NEWS →The Valve Wire summarizes; we link out to primary sources for verification.
More in Aortic Valve (TAVR/TAVI)
- Aortic Valve (TAVR/TAVI)· Cardiovascular intervention and therapeuticsTAVI-TEC: an AI-based tool for procedural planning of transcatheter aortic valve implantation.
- Aortic Valve (TAVR/TAVI)· JACC. AdvancesMitral Regurgitation after TAVR: Sex Differences and Low-Flow Low-Gradient Aortic Stenosis.
- Aortic Valve (TAVR/TAVI)· Frontiers in cardiovascular medicineCase Report: Brugada syndrome uncovered by delivery in a 32-year-old patient.
Elsewhere in Today’s Issue
- Mitral Valve (Repair & Replacement)· JACC. Case reportsParallel Septal Balloon Occlusion for Acute Right-to-Left Shunt During Mitral Transcatheter Edge-to-Edge Repair.
- Mitral Valve (Repair & Replacement)· JACC. AdvancesVery Severe, Not Too Severe: Reconsidering LV Dysfunction as a Barrier to Mitral TEER.
- Mitral Valve (Repair & Replacement)· Journal of cardiovascular echographyHigh Incidence of Short-term Subsequent Atrial Fibrillation Following Restrictive Filling Mitral Flow Profile in Patients without Structural Heart Disease.